SeekingAlpha  Aug 17  Comment 
By ChinaBio Today: Deals and Financings ZAI Lab Limited, a novel drug development company located in Shanghai, broke out of stealth mode by announcing a major deal: the company has obtained global rights for two novel compounds from Sanofi...
Motley Fool  Aug 16  Comment 
Biotech partnerships, an IPO that wasn't, and how big data is fighting Ebola.
SeekingAlpha  Aug 14  Comment 
By Psycho Analyst: Pundits of all stripes are opining about the Mannkind-Sanofi partnership without knowing any of the facts. Many statements being made both by bulls and bears display a lack of understanding of the product itself, its potential...
Motley Fool  Aug 13  Comment 
Quotes from MannKind Corp.'s conference calls.
SeekingAlpha  Aug 13  Comment 
By Jeff Eiseman: The partnership between Sanofi (NYSE:SNY) and MannKind (NASDAQ:MNKD) calls for all of each company's relevant present and prior costs to be counted when calculating net profits. This does not mean, as at least one commenter has...
StreetInsider.com  Aug 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Veracyte+%28VCYT%29+Tops+Q2+EPS+by+2c%2C+Amends+Agreement+with+Sanofi%27s+Genzyme/9750330.html for the full story.
FierceBiotech  Aug 13  Comment 
InterMune's promising treatment for a rare lung disease has put it in Big Pharma's crosshairs, according to a report, news that sent the biotech's shares soaring as much as 20% on Wednesday.
SeekingAlpha  Aug 13  Comment 
By Trevor Lowenthal: In June, I wrote a bull article on MannKind (NASDAQ:MNKD), with a conservative thesis stating that while regulatory approval for Afrezza was priced into the stock, the company's long-term prospects as an emerging competitor...
SeekingAlpha  Aug 13  Comment 
By Spencer Osborne: The excitement of the new deal between MannKind (NASDAQ:MNKD) and Sanofi (NYSE:SNY) has now been absorbed, and the street is now assessing how it feels the deal will impact MannKind. The equity currently trades at a market cap...
SeekingAlpha  Aug 12  Comment 
By George Rho: MannKind Corporation (NASDAQ: MNKD) and France-based Sanofi (NYSE: SNY) announced early yesterday morning (August 11, 2014) that they have entered into a worldwide exclusive licensing agreement for the development and...


Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki